Access
To read this article in full you will need to log-in or choose from the options on the right.
Distillery: Techniques - Drug platforms
SciBX 2(37); doi:10.1038/scibx.2009.1426
Published online Sep. 24 2009
Extra navigation
Theophylline-activated small interfering RNA expression platform
siRNAs fused to aptazymes could provide a platform for developing inducible siRNA therapeutics. Further details on the research, next steps and licensing status are discussed in the article.
To read this article in full you will need to log-in or choose from the options on the right.
